全文获取类型
收费全文 | 416篇 |
免费 | 10篇 |
国内免费 | 1篇 |
专业分类
妇产科学 | 1篇 |
基础医学 | 38篇 |
口腔科学 | 5篇 |
临床医学 | 19篇 |
内科学 | 6篇 |
皮肤病学 | 1篇 |
神经病学 | 222篇 |
特种医学 | 13篇 |
外科学 | 16篇 |
综合类 | 48篇 |
预防医学 | 15篇 |
眼科学 | 1篇 |
药学 | 19篇 |
中国医学 | 1篇 |
肿瘤学 | 22篇 |
出版年
2023年 | 5篇 |
2022年 | 5篇 |
2021年 | 13篇 |
2020年 | 21篇 |
2019年 | 13篇 |
2018年 | 16篇 |
2017年 | 8篇 |
2016年 | 9篇 |
2015年 | 13篇 |
2014年 | 19篇 |
2013年 | 21篇 |
2012年 | 12篇 |
2011年 | 18篇 |
2010年 | 19篇 |
2009年 | 17篇 |
2008年 | 18篇 |
2007年 | 13篇 |
2006年 | 23篇 |
2005年 | 11篇 |
2004年 | 9篇 |
2003年 | 14篇 |
2002年 | 13篇 |
2001年 | 7篇 |
2000年 | 10篇 |
1999年 | 2篇 |
1998年 | 8篇 |
1997年 | 8篇 |
1996年 | 7篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1993年 | 1篇 |
1992年 | 2篇 |
1991年 | 5篇 |
1990年 | 8篇 |
1989年 | 2篇 |
1987年 | 9篇 |
1986年 | 2篇 |
1985年 | 5篇 |
1984年 | 5篇 |
1982年 | 4篇 |
1981年 | 5篇 |
1980年 | 3篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1975年 | 3篇 |
1974年 | 1篇 |
排序方式: 共有427条查询结果,搜索用时 31 毫秒
1.
2.
研究了电化学治疗昆明小鼠肉瘤的疗效,并分析其机理。在体外将S-180细胞用不同参数的电场处理,研究适合电化学治疗的电场条件。通过复制肉瘤模型,将肉瘤小鼠随机分成4组:对照组、电疗组、化疗组、电化疗组。研究了不同处理组的肿瘤抑瘤率、治愈率以及小鼠的自由基代谢水平。结果电化疗组的抑瘤率、治愈率都显著高于化疗组和电疗组(P<0.05),电化疗组小鼠受到氧自由基的攻击显著降低,免疫力提高。分析机理发现,电化学治疗肿瘤的机理可能至少涉及细胞膜通透性提高、细胞的耐药性降低、机体的免疫力提高三个方面。 相似文献
3.
The urinary excretion of 3-methoxy, 4-hydroxyphenyl-glycol, (3-MHPG) was measured in 20 unipolar depressed patients before treatment with imipramine and electroconvulsive therapy (ECT) to investigate the relationship between pretreatment urinary excretion of 3-MHPG and clinical response. There was no difference in 3-MHPG excretion for depressed patients and controls. There was no significant difference between the mean percentage reduction of Hamilton Depression Rating Scale Scores in "low" and "high" excretors of 3-MHPG in the imipramine and ECT group of patients after four weeks of treatment. 相似文献
4.
18F-FDG PET显像在鼻咽癌诊断治疗中的价值 总被引:3,自引:1,他引:3
目的:探讨18F-FDG PET显像在鼻咽癌诊断治疗中的价值.方法:35例鼻咽癌PET与同期CT、MRI、骨ECT诊断结果比较分析,全部经病理组织学证实.结果:35例鼻咽癌PET与临床和CT、MRI、骨ECT诊断相符31例(88.6%),诊断不符4例(11.4%),其中真阴性2例和假阴性2例,1例ECT疑为多处骨转移,PET未发现核素浓聚改变,随访排除了骨转移;1例MRI疑为复发,PET未发现核素浓聚改变,病理及随访排除了复发;1例CT诊断肝转移,1例MRI诊断桥脑转移,PET均未发现核素浓聚改变.PET检测出CT、MRI和ECT未发现的转移灶6例(17.1%).结论:18F-FDG PET对鼻咽癌定性诊断具有较高的准确性和特异性,在诊断淋巴结和远处转移方面优于CT和MRI;诊断肝、脑转移有假阴性表现,提示PET应结合CT、MRI进行综合分析,才能作出正确的诊断. 相似文献
5.
电化学治疗对肿瘤病人免疫功能的影响 总被引:7,自引:0,他引:7
20例晚期癌症病人接受电化学治疗(ECT),治疗后所有病例的肿物均有不同程度缩小,其中4例出现ECT后的远隔效应,即运高电化学治疗电极的转移灶减小。免疫参数(OKT3,OKT4/OKT8,自然杀伤细胞活动度NKA,淋巴细胞转化实验LTT)在ECT前后发生明显改变。所有这些均提示ECT能增强人体免疫功能。 相似文献
6.
In the second part we focus on two treatment strategies that may overcome the main limitations of current antidepressant drugs. First, we review the experimental and clinical evidence supporting the use of glutamatergic drugs as fast-acting antidepressants. Secondly, we review the involvement of microRNAs (miRNAs) in the pathophysiology of major depressive disorder (MDD) and the use of small RNAs (e.g.., small interfering RNAs or siRNAs) to knockdown genes in monoaminergic and non-monoaminergic neurons and induce antidepressant-like responses in experimental animals.The development of glutamatergic agents is a promising venue for antidepressant drug development, given the antidepressant properties of the non-competitive NMDA receptor antagonist ketamine. Its unique properties appear to result from the activation of AMPA receptors by a metabolite [(2 S,6 S;2 R,6 R)-hydroxynorketamine (HNK)] and mTOR signaling. These effects increase synaptogenesis in prefrontal cortical pyramidal neurons and enhance serotonergic neurotransmission via descending inputs to the raphe nuclei. This view is supported by the cancellation of ketamine's antidepressant-like effects by inhibition of serotonin synthesis.We also review existing evidence supporting the involvement of miRNAs in MDD and the preclinical use of RNA interference (RNAi) strategies to target genes involved in antidepressant response. Many miRNAs have been associated to MDD, some of which e.g., miR-135 targets genes involved in antidepressant actions. Likewise, SSRI-conjugated siRNA evokes faster and/or more effective antidepressant-like responses. Intranasal application of sertraline-conjugated siRNAs directed to 5-HT1A receptors and SERT evoked much faster changes of pre- and postsynaptic antidepressant markers than those produced by fluoxetine. 相似文献
7.
多发性骨髓瘤的临床及影像学分析 总被引:6,自引:0,他引:6
目的:探讨多发性骨髓瘤的临床表现特征与影像学的诊断价值.方法:回顾性分析32例经骨髓穿刺或手术病理证实的MM患者的影像学资料,对其临床特征和影像学表现特点进行综合分析.结果:多发性骨髓瘤最常见的临床表现有全身性疼痛、贫血、出血、肾功能损害、发热、肺部感染和全身乏力等.32例患者不同部位X线摄片的阳性率分别为颅骨85%、肋骨56%、脊椎53%、肩胛骨46.1%、骨盆43%、股骨37.5%、胫骨33.3%。15例脊椎CT均显示明显骨质破坏。12例脊椎MRI中有10例示明显信号改变。18例ECT全身骨扫描全部出现多骨的浓聚灶.结论:多发性骨髓瘤起病隐匿。临床表现多样化且缺乏特征性。典型影像学表现为多发穿凿状或虫蚀状骨质破坏及广泛的骨质疏松;X线平片检查尤其是头颅、骨盆、腰椎、肋骨及骨痛部位。应作为多发性骨髓瘤初诊的常规筛查,CT、MRI及ECT检查对早期和不典型多发骨髓瘤病变的显示明显优于X线平片检查. 相似文献
8.
BackgroundBDNF blood levels are reduced in MDD. They can be increased with pharmacologic treatment and ECT, but it is not clear whether the combination of treatments promotes an additional increase. The present study aims to evaluate whether combined treatment promotes an increase in BDNF, restoring the level to that of non-depressed controls.MethodsNinety-nine adult inpatients were invited to participate in this naturalistic prospective cohort study between May 2011 and April 2013. Diagnosis was made by MINI, and the symptoms were evaluated at admission and at discharge by HDRS-17. Those inpatients with a diagnosis of depression were included and divided into two groups: those who underwent combined ECT and medication (31 subjects) and those who used only pharmacotherapy (68 subjects). Serum BDNF was measured in blood samples collected at admission and discharge. One hundred healthy blood donors without any psychiatric diagnosis were included as a control group.ResultsThere were no significant differences in serum BDNF levels between the combined and pharmacological groups at admission and at discharge, and no significant variation in BDNF occurred in any group during the treatment. There were no interactions between time and treatment groups nor significant time effects or treatment group effects for BDNF in the Generalized Estimating Equation Model (GEE). The control group had significantly higher serum BDNF levels in comparison with each of the treatment groups at admission and discharge (p = 0.00).ConclusionCombination of ECT with pharmacological treatment did not result in increased serum BDNF levels and did not restore levels to that of controls. 相似文献
9.
10.